Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 2, 2005, Pages 113-120

  Malonne, Hugues ^b   Coffiner, M ^a   Fontaine, D ^b   Sonet, B ^a   Sereno, A ^a   Peretz, A ^c   Vanderbist, F ^a  

^a Laboratoires SMB SA   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Low back pain; Once daily formulation; Osteoarthritis; Tolerability; Tramadol

Indexed keywords

CLOTIAZEPAM; COCODAMOL; DICLOFENAC; IBUPROFEN; KETOPROFEN; NAPROXEN; PARACETAMOL; SERTRALINE; SULPIRIDE; TETRAZEPAM; TRAMADOL; TRAZODONE; VENLAFAXINE; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LABORATORY TEST; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; RADIOGRAPHY; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; VERTIGO; VOMITING;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOW BACK PAIN; MALE; NAUSEA; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN, INTRACTABLE; PATIENT SATISFACTION; TRAMADOL; TREATMENT OUTCOME; VOMITING;

EID: 27744586420     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00624.x     Document Type: Article

References (26)

1. Bannwarth B (1999) Risk-benefit assessment of opioids in chronic noncancer pain. Drug Safety, 21, 283-296.
2. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003) Neuropsychological effects of long-term opioid use in chronic pain patients. Journal of Pain Symptom and Management, 26, 913-921.
3. Kjaersgaard-Andersen P, Nafei A, Skov O et al. (1990) Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain, 43, 309-318.
4. Portenoy RK (2000) Current pharmacotherapy of chronic pain. Journal of Pain and Symptom Management, 19, S16-S20.
5. Collart L, Luthy C, Favario-Constantin C, Dayer P (1993) Duality of the analgesic effect of tramadol in humans. Schweizerische Medizinische Wochenschrift, 123, 2241-2243.
6. Dayer P, Collart L, Desmeules J (1994) The pharmacology of tramadol. Drugs, 47(Suppl. 1), 3-7.
7. Desmeules JA, Piguet V, Collart L, Dayer P (1996) Contribution of monoaminergic modulation to the analgesic effect of tramadol. British Journal of Clinical Pharmacology, 41, 7-12.
8. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics, 260, 275-285.
9. Raffa RB, Friderichs E, Reimann W et al. (1993) Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. Journal of Pharmacology and Experimental Therapeutics, 267, 331-340.
10. Ehrenreich H, Poser W (1993) Dependence on tramadol. Clinical Investigation, 72, 76.
11. Knisely JS, Campbell ED, Dawson KS, Schnoll SH (2002) Tramadol post-marketing surveillance in health care professionals. Drug and Alcohol Dependence, 68, 15-22.
12. Preston KL, Jasinski DR, Testa M (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug and Alcohol Dependence, 27, 7-17.
13. Malonne H, Sonet B, Streel B, Lebrun S, De Niet S, Sereno A, Vanderbist F (2004) Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol. British Journal of Clinical Pharmacology, 57, 270-278.
14. Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F (2004) Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics, 26, 1774-1782.
15. Brandt KD (2000) The role of analgesics in the management of osteoarthritis pain. American Journal of Therapeutics, 7, 75-90.
16. Wegman A, van Tulder M, Stalman W, de Vries T (2004) Nonsteroidal anti-inflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. Journal of Rheumatology, 31, 344-354.
17. Towheed TE, Judd MJ, Hochberg MC, Wells G (2003) Acetaminophen for osteoarthritis. Cochrane Database System Review CD004257.
18. Tacconelli S, Capone ML, Patrignani P (2004) Clinical pharmacology of novel selective COX-2 inhibitors. Current Pharmaceutical Design, 10, 589-601.
19. Yuan Y, Hunt RH (2003) Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003? Inflammopharmacology, 11, 337-354.
20. Bijlsma JW (2002) Analgesia and the patient with osteoarthritis. American Journal of Therapeutics, 9, 189-197.
21. Emkey R, Rosenthal N, Wu SC, Jordan D, Kamin M (2004) Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal anti-inflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. Journal of Rheumatology, 31, 150-156.
22. Schnitzer TJ, Kamin M, Olson WH (1999) Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study. Arthritis and Rheumatism, 42, 1370-1377.
23. Silverfield JC, Kamin M, Wu SC, Rosenthal N (2002) Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clinical Therapeutics, 24, 282-297.
24. Bodalia B, McDonald CJ, Smith KJ, O'Brien C, Cousens L (2003) A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. Journal of Pain and Symptom Management, 25, 142-149.
25. Jensen EM, Ginsberg F (1994) Tramadol versus dextropropoxyphene in the treatment of osteoarthritis. Drug Investigation, 8, 211-218.
26. Katz WA (1996) Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs, 52 (Suppl. 3), 39-47.